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The LTRs of all primate lentiviruses contain long U3 regions overlapping the nef gene. To assess the relevance of the modulatory U3
region for HIV-1 replication, we inactivated the T-rich region, the Polypurine tract and attachment (att) sequences in nef by silent mutations
and inserted intact cis-regulatory elements just upstream of the core enhancer. These modifications severely truncated the U3 region and
eliminated the nef overlap. The resulting HIV-1 mutants expressed functional Nef, replicated efficiently and caused CD4+ T cell depletion in
ex vivo-infected lymphoid tissue suggesting that the modulatory U3 region might not be essential for efficient HIV-1 gene expression and
AIDS pathogenesis.
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Retroviral genomes are flanked by the long terminal
repeats (LTRs), which are divided in three regions: U3, R
and U5 (Gaynor, 1992; Varmus, 1988). The U3 region of
human and simian immunodeficiency viruses (HIV and SIV,
respectively) contains the basal promoter (nt 78 to 1), a
core enhancer (nt 105 to 79) and a very long modulatory
region (nt 454 to 104) (Gaynor, 1992). The three
consensus SP1 binding sites in the basal promoter and the
two NF-kB binding sites in the core enhancer are the major
elements involved in the regulation of HIV-1 transcription
(Gaynor, 1992). Numerous studies also proposed, however,
that the modulatory U3 region influences viral gene
expression. Early reports indicated that this region might
contain a negative regulatory element (Rosen et al., 1985;
Siekevitz et al., 1987). A large number of cellular factors0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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Nu¨rnberg, 91052 Erlangen, Germany.including NF-AT, Ets-1, USF, AP-1, COUP and Sp1 have
been proposed to interact with the modulatory region and to
contribute to HIV-1 LTR promoter activity (Pereira et al.,
2000). However, the modulatory U3 region is also entirely
overlapped by the nef gene (Kirchhoff et al., 1995). Studies
with SIV indicate that the upstream U3 sequences (herein
after referred to as US region) might serve mainly as a nef
coding sequence. Initially, it has been shown that additional
deletions in the modulatory U3 region emerge in rhesus
macaques infected with a nef-deleted SIVmac mutant
(Kirchhoff et al., 1994). A subsequent study demonstrated
that nucleotide changes in the US region, which did not alter
the Nef coding sequence, did not attenuate the virulence of
SIVmac (Ilyinskii et al., 1994). More recently, we have
shown that an SIV variant containing a grossly truncated U3
region that does not overlap the nef gene replicated
efficiently and caused disease in infected macaques (Mu¨nch
et al., 2001).
These previous studies demonstrated that the conserved
overlap between nef and the U3 region is not obligatory
for efficient replication and pathogenicity of SIV. Findings
from HIV-1-infected long-term survivors demonstrate that
the HIV-1 US region is also only preserved in the05) 313 – 320
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al., 1995; Kirchhoff et al., 1995; Rhodes et al., 2000;
Salvi et al., 1998). However, these HIV-1 variants were
strongly attenuated and it remained elusive whether the
US region might contribute to viral replication and
pathogenicity in the presence of an intact nef gene. We
have previously mutated the critical cis-regulatory ele-
ments, encompassing the T-rich region, polypurine tract
and attachment (att) sequences required for integration
(herein after referred to as TPI region) in the SIVmac239
nef gene (Mu¨nch et al., 2001). The resulting SIV mutants
had a short U3 region which did not overlap the nef gene.
Thus, they allow to study Nef function in the context of
replication-competent viruses without the complications of
overlapping LTR sequences. We also demonstrated that
the modulatory U3 region is not required for a virulent
phenotype in infected macaques (Mu¨nch et al., 2001). The
sequence homology between HIV-1 and SIVmac Nef
proteins is limited and several activities are mediated by
different domains. Some functions, such as down-modu-
lation of CD3 and CD28, are only efficiently carried out
by SIVmac but not by HIV-1 Nef proteins (Schindler et
al., 2004). Thus, some observations made with SIVmac
Nef variants might not be relevant for HIV-1. Furthermore,
although a large number of interacting cellular factors
have been described (Pereira et al., 2000), the role of the
HIV-1 modulatory U3 region for LTR-directed transcrip-
tion and viral replication is less clear than that of SIVmac.
In the present study, we generated HIV-1 variants without
the overlap between nef and U3 sequences. Our goals
were to assess the relevance of the modulatory U3 region
for viral replication and cytopathicity and to establish an
experimental system allowing to study HIV-1 Nef function
independently of overlapping LTR and critical cis-regu-
latory sequences.Results and discussion
A total of 12 point mutations were introduced into the nef
gene to inactivate the cis-regulatory TPI element (Fig. 1A).
These changes did not alter the predicted Nef amino acid
sequence. Full-length or prematurely truncated wild type
(wt) and TPI mutant nef alleles were inserted into proviral
NL4-3 constructs containing a 222-bp deletion in the nef
unique region alone (D1) or in conjunction with a 266-bp
U3 deletion (D1D2) (Fig. 1B). The 3V ends of the mutant
forms of NL4-3 generated are shown in Fig. 1B. TPImut
differs from NL4-3wt only by the specific mutations in the
TPI region. The D1-derived constructs contain intact or
mutated nef genes upstream of the full-length LTR resulting
in a duplication of the U3 region and an enlarged viral
genome. In comparison, the D1D2-derived NL4-3 mutants
contain just the intact U3 sequences in the nef gene and 83-
bp of the original sequence upstream of the NF-nB sites.
The right panel of Fig. 1B shows the 5VLTRs predicted afterreverse transcription. The TPImut NL4-3 variant is pre-
dicted to be inactive because it lacks sequences critical for
reverse transcription and integration. In contrast, the nef+D1
and nef+D1D2 HIV-1 and otherwise isogenic forms
containing two premature stop signal at the 72 and 73
codons of the nef gene (nef*) contain two copies of the TPI
elements, which might result in two different forms of the
proviral 5VLTR. Finally, the nefTPImutD1 mutant is pre-
dicted to contain the full-length U3 region at the 5Vend of
the genome, whereas the U3 region of nefTPImutD1D2 is
predicted to be grossly truncated. The HIV-1 NL4-3
nefTPImutD1D2 genome contains U3 regions that are
266-bp shorter than the 454-bp NL4-3wt U3 region.
Nonetheless, it contains all known coding sequences and
cis-acting elements. In addition to the mutants shown in Fig.
1B, forms containing disrupted nef genes (nef *) or just the
five mutations localized in the polypurine tract (Pmut), were
also generated. Furthermore, we constructed otherwise
isogenic forms containing the 005pf135 V3 region (Papkalla
et al., 2002) in the viral envelope to generate CCR5-tropic
HIV-1 NL4-3 variants.
To investigate the infectivity and replicative potential of
the HIV-1 TPI mutants, virus stocks were generated by
transient transfection of 293T cells as described previously
(Rucker et al., 2004). With the exception of NL4-3 TPImut
and Pmut, all mutant viruses replicated efficiently in Jurkat
T and CEM  174 5.25 M7 cells. Genomic DNA was
extracted at the end of culture for PCR and sequence
analysis. PCR amplification with primer p1, which binds to
the US region, paired with p2 binding to the non-translated
region downstream of the 5VLTR and upstream of gag,
yielded fragments of 655-bp and 761-bp for the NL4-3wt-
and nef+D1D2-infected cells, respectively (Fig. 1C). The
size of the nef+D1D2-derived fragment is enlarged by 106-
bp due to the insertion of a fragment encompassing the T-
rich region, the polypurine tract and 83-bp of upstream
U3 sequences. Consistent with the absence of the US
region at the 5V end of the proviral genome (Fig. 1B), no
PCR fragment was obtained from DNA extracted from
nefTPImutD1D2-infected cells (Fig. 1C, lane 4). In
contrast, PCR amplification of p1 paired with p4, which
binds in the U5 region (Fig. 1B), yielded amplification
products of the predicted size (541-bp and 646-bp,
respectively) for all three infected cell cultures (Fig. 1C,
lanes 7–9). The differences in amplification efficiency are
in agreement with the fact that p1 binds to both LTRs of
the NL4-3wt and nef+D1D2 proviruses but only to the
3VLTR of the nefTPImutD1D2 proviral sequence. Predict-
ably, amplification with p1 and p5, which binds to the 5V
end of the U3 region, resulted in amplification products
of 344-bp for cells infected with the NL4-3 mutant
viruses (Fig. 1C, lanes 13 and 14). In contrast, no specific
PCR product was obtained with DNA extracted from
NL4-3wt-infected cells because 3V primer (p5) binds only
upstream of the 5Vprimer (p1) in the wild type LTR (Fig.
1B). In sum, PCR amplification and sequence analysis of
Fig. 1. Mutant construction and HIV-1 NL4-3 nef/LTR variants analyzed. (A) NL4-3 constructs containing a deletion of 222-bp in the nef unique region alone
(D1) or together with a deletion of 266-bp in the U3 region (D1D2) (Gibbs et al., 1994), were utilized to generate nef/LTR variants. The black bar indicates the
position of the deletions. As indicated below, 12 (TPImut) or 5 (Pmut) silent point mutations were introduced in the TPI-region and cloned into NL4-3wt
(TPImut, Pmut) or the D1 (nefTPImutD1, nefPmutD1) and D1D2 (nefTPImutD1D2, nefPmutD1D2) proviral constructs. (B) Schematic presentation of the HIV-
1 NL4-3 constructs analyzed (left), and the deduced 5VLTR promoter region (right). All mutants shown contain intact nef genes. TPImut differs from NL4-3wt
only by the specific point mutations in the TPI region; nef+D1 and nef+D1D2 contain NL4-3wt nef genes; nefTPImutD1 and nefTPImutD1D2 TPI-mutated nef
alleles. Otherwise, isogenic forms with a premature stop signal in the nef ORF were also generated. The D1D2 forms contain only 83-bp of US sequences.
Abbreviations: E-CP, enhancer-core promoter; Int, U3-terminal sequences required for integration. Arrows indicate the positions of primers used for PCR
amplification. (C) HIV-1 5VLTR and nef-3VLTR sequences were amplified from genomic DNA extracted from infected CEM  174 5.25 M7 cells. The
arrowheads indicate DNA fragments of the expected size. Similar results were obtained with infected Jurkat T cells.
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demonstrated that all proviruses contained the predicted
U3 sequences at the 5V and 3V ends of their genomes.
Western blot analysis showed that HIV-1 variants
containing NL4-3wt or TPI-mutated nef genes, but not
the nef* variants, expressed normal quantities of full-
length Nef proteins (Fig. 2 and data not shown). As
expected from previous studies (Papkalla et al., 2002),
intact nef genes strongly enhanced infectivity of both R5-
and X4-tropic HIV-1 NL4-3 variants (Fig. 3). The
TPImut variant missing critical cis-regulatory elementswas grossly defective. In contrast, the infectivity of the
nef+D1D2 and nefTPImutD1D2 variants, containing intact
TPI sequences downstream of nef and upstream of the
core enhancer, was only moderately reduced compared to
NL43wt (Fig. 3). Similar results were obtained with the
Pmut forms and the D1-derived constructs (data not
shown). These results demonstrate that the TPI-mutated
nef alleles enhance HIV-1 infectivity and that the
presence of the full-length modulatory U3 region at the
5V end of the viral genome moderately enhances viral
gene expression and/or infectivity.
Fig. 2. Mutations in the TPI region do not impair HIV-1 Nef expression.
Nef and p24 core antigen expression in 293T cells transiently transfected
with the indicated proviral NL4-3 constructs was verified by immunoblot
using rabbit-anti-HIV-p24 serum provided by the AIDS Research and
Reference Reagent Program or an anti-HIV-1 Nef mAb directed against
amino acids 151 to 170 (Advanced Biotechnologies). As a positive control,
cells were transfected with the pCG-NL4-3Nef vector, which contains the
CMV promoter and coexpresses Nef and the green fluorescent protein (lane
2). Similar results were obtained in an independent experiment.
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1 NL4-3 TPI variants in human peripheral blood mono-
nuclear cells (PBMC). All NL4-3 variants, except the
TPImut and Pmut forms, replicated in pre-stimulated
PBMC, although intact nef genes resulted in moderately
increased replication efficiency (Fig. 4A). As expected
(Chowers et al., 1994; Miller et al., 1994; Spina et al.,
1994), Nef increased HIV-1 replication more strongly when
PBMC were infected immediately after isolation and
stimulated 3 days later (Fig. 4B). The D1D2-derived
constructs containing the wt, Pmut or TPImut mutant nef
alleles replicated with NL4-3wt-like efficiency in the PBMC
cultures, although the replication kinetics were slightly to
moderately delayed compared to NL4-3wt in PBMC
derived from some blood donors (data not shown). Thus,
these constructs allow to assess the effect of HIV-1 nef on
viral infectivity and replication without the restriction of
overlapping LTR and cis-regulatory sequences. FurtherFig. 3. HIV-1 nef alleles containing changes in the TPI-region enhance viral infect
tropic (right) HIV-1 NL4-3 LTR/nef variants. Infections were performed in triplicat
3.0 ng p24 antigen. Shown are average values T SD. Infectivity is shown relat
experiments with different virus stocks.analysis showed that amino acid changes in the region of
Nef that is encoded by the TPI-region impair Nef protein
stability and reduce HIV-1 infectivity and replication (data
not shown). Thus, this region in Nef is conserved because it
contains critical cis-regulatory elements and is important for
stable Nef expression.
The genomes of all primate lentiviruses are organized so
that nef overlaps the 3VLTR suggesting that this genomic
organization is advantageous in the infected host. We have
previously shown, however, that an SIVmac239 TPI variant
containing a U3 region that is shortened by 384-bp and does
not overlap nef is pathogenic in infected rhesus macaques
(Mu¨nch et al., 2001). The homology between the HIV-1 and
SIV U3 LTR sequences is low and it has been demonstrated
that the SIVmac U3 region shows a higher degree of
functional redundancy compared to the corresponding HIV-
1 region (Ilyinskii and Desrosiers, 1998; Po¨hlmann et al.,
1998). To further evaluate the possible relevance of the
modulatory U3 region for HIV-1 replication and pathoge-
nicity in infected humans, we infected ex vivo tonsillary
human lymphoid tissue (HLT) with the HIV-1 nef/LTR
variants. This experimental system is likely of high
physiological relevance because it does not require exoge-
nous stimulation and the complexity of cell types mimics
the in vivo situation (Glushakova et al., 1995; Glushakova
et al., 1999). Mutations in the TPI region (nef+TPImut,
nef*TPImut) disrupted the replicative capacity of HIV-1
(Fig. 5A). Insertion of an intact TPI region upstream of the
core enhancer (nef+TPImut) restored the ability of both X4-
and R5-tropic HIV-1 variants to spread efficiently in ex
vivo-infected HLT. Similarly to the results obtained using
human PBMC, however, the mutant viruses replicated with
delayed kinetics in tissues derived from some donors
(example shown in Fig. 5A, lower panel). Nevertheless,
these results demonstrate that elimination of the nef-LTR
overlap and truncation of the U3 region does not have major
disruptive effects on the ability of HIV-1 to replicate inivity. P4-CCR5 cells were infected with the indicated X4-tropic (left) or R5-
e with virus stocks of the X4- or R5-tropic HIV-1 NL4-3 variants containing
ive to HIV-1 NL4-3wt. Similar results were obtained in two independent
Fig. 4. HIV-1 NL4-3 variants without overlapping nef/U3 sequences replicate efficiently in human PBMC. (A) PBMC were PHA/IL-2-stimulated for 3 days
prior to infection. (B) Unstimulated PBMC were infected with X4-tropic HIV-1 nef/LTR variants immediately after isolation, stimulated with PHA/IL-2 for 48
h 3 days later and cultured for 18 days. Virus production was monitored by reverse transcriptase assay as described (Potts, 1990). Similar results were obtained
in independent experiments using different virus stocks and PBMC from different donors. PSL, photon-stimulated light emission.
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replication, the X4-tropic form of the nef+TPImutD1D2
mutant virus depleted CD4+ T cells as effectively as HIV-1Fig. 5. Effect of a truncated U3 region on HIV-1 replication and CD4+ T
cell depletion in HLT. (A) Replication of the indicated X4-tropic (left) or
R5-tropic (right) HIV-1 NL4-3 Nef variants in ex vivo-infected HLT
derived from two donors. Infections were performed without adding
exogenous IL-2 with virus stocks containing 10 ng of p24 antigen and
virus production was measured by p24 ELISA at the indicated days post-
infection. (B) Percentages of CD4+ T cells in the tissue blocks (left bars)
and cells that migrated in the gel foams (right bars) at the end of culture
at 15 days post-infection. Tissue culture, infections and FACS analysis
were performed as described previously (Rucker et al., 2004). NL4-3wt-
like and moderately delayed replication kinetics, respectively, were also
observed in two independent experiments using tissues derived from
different donors.NL4-3wt in tissues derived from donor A (Fig. 5B, left
panel) but was partially attenuated in HLT derived from
donor B (Fig. 5B, right panel). In comparison, the nef-
defective forms consistently depleted CD4+ T cells less
efficiently. Predictably, the replication-incompetent nef+T-
PImut and nef*TPImut HIV-1 variants did not cause
cytopathic effects in ex vivo-infected HLT. We did also
observe a minor reduction of CD4+ T cells in HLT infected
with the R5-tropic forms of NL4-3 expressing full-length
Nef proteins. It has been previously shown that R5- and X4-
tropic HIV-1 replicate with comparable efficiency and are
equally cytopathic for their T cell targets in HLT (Grivel and
Margolis, 1999). However, because only a small fraction of
CD4+ T cells in HLT expresses CCR5, only up to 20% were
depleted (data not shown).
In sum, our results clearly demonstrate that HIV-1
lacking the modulatory U3 region and the nef-LTR overlap
can replicate efficiently and cause CD4+ T cell depletion in
human T cells and ex vivo-infected HLT. Compared to NL4-
3wt, however, the nef+TPImutD1D2 mutant virus showed
delayed replication kinetic and attenuated cytopathic effects
in some ex vivo-infected HLTs. In comparison, analogous
SIV nef-LTR variants consistently replicated with 239wt-
like kinetics in cell culture assays and in rhesus macaques
(Mu¨nch et al., 2001). These data are in agreements with
previous findings demonstrating that the SIVmac U3 region
shows a higher degree of functional redundancy than that of
HIV-1 (Po¨hlmann et al., 1998) and indicate that the
modulatory U3 region of HIV-1 contributes moderately to
viral gene expression. Our results obtained in ex vivo-
infected HLT suggest that HIV-1 variants with short U3
regions that do not overlap nef might be pathogenic in vivo,
although they will most likely not induce disease as
consistent as wild type HIV-1 strains. Why the modulatory
HIV-1 U3 region contribute to optimal viral spread in cells
or tissues from some donors remains to be clarified. Possible
explanations might be donor to donor variations in the
expression of specific transcription factors that bind to the
upstream U3 sequences. Importantly, intact nef genes
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demonstrating that the HIV-1 constructs described in this
study are useful to analyze Nef function without the
restriction and complications of overlapping LTR and
critical cis-regulatory elements.Materials and methods
Mutant construction
Site-directed mutagenesis to generate the HIV-1 NL4-3
TPI variants was performed by spliced overlap extension
(SOE) PCR as described previously (Mu¨nch et al., 2001). All
PCR products were cloned in pCR2.1-Topo vector (Invitro-
gen) and sequenced on both strands. First a SmaI site was
introduced in pBRNL4-3 just upstream of the PPT/Int
sequences using pBamHI and pLsmaNRE (left half) and
pRsmaNRE and pXbaI (right half). SOE PCR of gel purified
fragments was performed with outer primers pBamHi and
pXbaI, sequenced and cloned via BamHI and XbaI into
pBRNL4-3, resulting in the generation of pBRNL4-3(D1).
Next, env-nef or env-nef* fragments were generated using
primer pairs pBamHI and pnef*SmaI with pBRNL4-3wt and
NL4-3nef* as template. pnef*SmaI introduces a stop codon
downstream of the nef ORF. PCR fragments were cloned into
pBRNL4-3(D1) using BamHI and SmaI resulting in the
generation of pBRNL4-3 nef+D1 and nef*D1. nefPmutD1
was generated by SOE PCR using outer primers pBamHI and
pnef*SmaI and PCR fragments as template obtained using
pBamHI and pLPPNLneu (left fragment) and pRPPNL and
pnef*Sma (right fragment). nefTPImutD1 was generated the
same way except that mutagenic primers were p5VPPT/
INTmut and p3VPPT/INTmut. PCR fragments were cloned in
pBRNL4-3(D1) via BamHI and SmaI. pBRNL4-3 nefPmut
and nefTPImutwere generated using the same strategy except
that the outer primer pXbaI was used instead of pnef*SmaI.
To generate pBRNL4-3 D1D2 PCR was performed with
pBRNL4-3(D1) as template and primer pairs pBamHI and
p5VDNRE (left fragment) and p3VDNRE and pXbaI (left
fragment). SOE PCR with gel purified PCR products was
performed using pBamHI and pXbaI and the resulting
fragment was cloned into pBRNL4-3. NL4-3 nef+D1D2,
nef*D1D2, nefPmutD1D2 and nefTPImutD1D2 were gen-
erated by cloning the corresponding mutants from D1
constructs into pBRNL4-3 D1D2 using BamHI and
SmaI. R5 tropic variants were generated by replacing the
wild type nef/LTR fragment of pBRNL4-3 005pf135
(Papkalla et al., 2002) with the indicated nef/LTR mu-
tants using HpaI and XbaI. Primer sequences were:
pRsmaNRE5V-GAAAATTTTTCACCGATGGGCCCTCTAG-
TCTAGATGTCGACGGAAC-3V; pLsmaNRE 5V-GTTCCGT-
CGACATCTAGAGGGCCCATCGGTGAAAAATTTTC-3V;
pRPPNL 5V-CACTTAATCGGGAAGGTCCGGTGGA-
AAGAGGAACTCCTTCACCGATTC-3V; pLPPNLneu 5V-
CATCTAGAATCGGTGAAGGAGTTCCTCTTTCC-ACCGGACCTTCCC-3V; p5DNRE 5V-CTTGAAGTA-
CTCCGGATGGGATATCTTGTCTTCTTT-3V; p3VDNRE 5V-
CCAAAGAAGACAAGATATCCCATCCGGAGTACTT-
CAAG-3V; p5VPPT/INTmut 5V-ATCTAGAATCGGTGA-
AGGAGTTCCTCTTTCCACCGAATCTCCCAAAC-3V;
p3VPPT/INTmut 5V-GAAACCCTCACTTAGTTTGGGA-
GATTCGGTGGAAAGAGGAACTCCTT-3V; pnef*Sma 5V-
ATGAAGTTCTTGACGACTTGCGCAGGGCCCCCT-3V;
pBamHI 5V-TAGTGAACGGATCCTTAGC-3V and pXbaI 5V-
GGTTGTCTAGAACTGCTAGAGATTTTCCACACT-3V.
Cells
CEM  174 5.25 M7 cells, kindly provided by
Nathaniel Landau, were kept in RPMI 1640 medium
supplemented with 10% fetal calf serum (FCS). P4-CCR5
cells, provided through the AIDS Research and Refer-
ence Reagent Program, Division of AIDS, NIAID, NIH
(Charneau et al., 1994), and 293T cells were kept in
DMEM medium supplemented with 10% FCS. Human
PBMC were isolated by use of lymphocyte separation
medium (Organon Teknika Corporation, Durham, N.C.)
and either cultured in RPMI (10% FCS; unstimulated) or
stimulated with RPMI (20% FCS) supplemented with 4
Ag/ml phytohemagglutinin (Sigma) and 10 ng/ml IL-2
(Strathmann) for 3 days.
Production of virus stocks and infection experiments
Virus stocks were produced by transient transfection of
293T cells as described previously (Rucker et al., 2004).
Briefly, 293T cells were transfected with plasmids
containing the entire HIV-1 NL4-3 genome by using a
CaPO technique. The culture medium was changed 1 day
after transfection, and the culture supernatant was
harvested the following day. Residual cells in the
supernatants were pelleted, the supernatants were passed
through 0.45-Am-pore-size filters and stored at 70 -C.
The content of viral p24 antigen was quantified by an
HIV p24 enzyme-linked immunosorbent assay kit
obtained through the AIDS Research and Reference
Reagent Program. P4-CCR5 cells (4000 cells per well)
were sown out in 96 well dishes in a volume of 100 Al
and infected after overnight incubation with virus stocks
containing 3 ng of p24 antigen in a total volume of 200
Al. Three days post-infection viral infectivity was detected
using the Gal Screen Kit (Tropix) as recommended by
the manufacturer. To calculate percent values, relative
light units per second (RLU/s) obtained for HIV-1 NL4-3
wild type infection were set to 100%. 2  105 un-
stimulated or stimulated PBMC were sown out in 150 Al
medium and infected with virus stocks containing 1 ng
p24 antigen in a total volume of 200 Al. Unstimulated
PBMC were stimulated 3 days post-infection with PHA (3
Ag/ml) and 10 ng/ml IL-2. Thereafter, all PBMC were
cultivated in RPMI containing 10 ng/ml IL-2. Supernatants
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added. The extent of viral replication was determined by
using a radioactive reverse transcription (RT) assay as
previously described (Potts, 1990). All experiments were
performed with at least four independent virus stocks in
triplicate.
HIV infection of human lymphoid tissue ex vivo
Human tonsillar tissue removed during routine tonsillec-
tomy and not required for clinical purposes was received
within 5 h of excision. The tonsils were washed thoroughly
with medium containing antibiotics and then sectioned into
2- to 3-mm blocks. These tissue blocks were placed on top
of collagen sponge gels in the culture medium at the air–
liquid interface and infected as described previously
(Glushakova et al., 1995, 1997). In a typical experiment, 3
to 5 Al of clarified virus containing medium was applied to
the top of each tissue block. Supernatants were collected at 3
day intervals and productive HIV infection was assessed by
measuring p24 antigen content. Flow cytometry was
performed on cells mechanically isolated from control and
infected tissue blocks and depletion of CD4+ T cells was
assessed as described previously (Glushakova et al., 1997).
Genomic DNA preparation and PCR analysis
2  106 CEM  174 5.25 M7 were sown out in 300 Al
medium in 48 well dishes and infected in a total volume of
500 Al with 10 ng of p24 antigen. 4 days post-infection fresh
cells were added. 10 dpi cells were pelleted, washed in PBS,
lysed in 100 Al cell lysis buffer (50 mM KCl, 10 mM Tris
pH 8.3, 2.5 mM MgCl2, 0.45% NP-40, 0.45% Tween-20
and 1 mg/ml proteinase K) and incubated for 1 h at 56 -C.
After proteinase inactivation for 10 min at 95 -C, 5 Al of
lysates were used for PCR analysis using oligonucleotides
p1 5V-GGCTACTTCCCTGATTGGCAGAA-3V, p2 5V-CC-
GTGCGCGCT-TCAGCAAGCCGAG-3, p4 5V-GGGTCT-
GAGGGATCTCTAGTTACC-3 and p5 5V-GGATA-
TCTTGTCTT-CTTTGGGAGTGA-3.
Western blot analysis
293T cells were transiently transfected in T-25 flasks, the
medium was changed 12 to 16 h after transfection and cells
were harvested 48 h after transfection. The cells were rinsed
with phosphate-buffered saline and lysed in RIPA-1 buffer
(1% Triton X-100; 0.15 M NaCl; 50 mM Tris–HCl pH 7.4;
5 mM EDTA). Immunoblots were performed using rabbit-
anti-HIV-p24 serum provided by the AIDS Research and
Reference Reagent Program or an anti-HIV-1 Nef mAb
directed against amino acids 151 to 170 (Advanced
Biotechnologies). As a positive control, cells were trans-
fected with the pCG-NL4-3Nef vector, which contains the
CMV promoter and coexpresses Nef and the green
fluorescent protein.Acknowledgments
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